Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143556 |
| CAS No | 2761668-93-1 |
| Mol.F. | C20H19N3OS2 |
| Mol.Wt. | 381.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143557 |
| CAS No | NA |
| Mol.F. | C12H13N4O5S : Na |
| Mol.Wt. | 325.3 : 23.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143558 |
| CAS No | NA |
| Mol.F. | C12H14N4O5S |
| Mol.Wt. | 326.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143559 |
| CAS No | NA |
| Mol.F. | C14H18N2O2 |
| Mol.Wt. | 246.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143560 |
| CAS No | NA |
| Mol.F. | C12H12N4O3 |
| Mol.Wt. | 260.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143561 |
| CAS No | NA |
| Mol.F. | C11H9N5O4 |
| Mol.Wt. | 275.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143562 |
| CAS No | NA |
| Mol.F. | C14H21N3O |
| Mol.Wt. | 247.34 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0143563 |
| CAS No | NA |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143564 |
| CAS No | NA |
| Mol.F. | C13H17N5O |
| Mol.Wt. | 259.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143565 |
| CAS No | 111348-65-3 |
| Mol.F. | C5H12N2O3 |
| Mol.Wt. | 148.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143566 |
| CAS No | NA |
| Mol.F. | C11H14N2O2 |
| Mol.Wt. | 206.24 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0143567 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143568 |
| CAS No | 2114-63-8 |
| Mol.F. | C15H14N2O3 |
| Mol.Wt. | 270.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143569 |
| CAS No | 60096-51-7 |
| Mol.F. | C6H10N2O4 |
| Mol.Wt. | 174.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143570 |
| CAS No | 6335-95-1 |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.17 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143571 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |